Table 1.

Demographics and clinical characteristics of the inflammatory bowel disease type unclassified patients

No. of patients, n (%)	36 (100)
Gender
Female	21 (58.3)
Male	15 (41.7)
Age (yr) (mean ± SD) at diagnosis	33.2 ± 13.1 (15-64)
Age (yr) (mean ± SD) at SBCE	35.9 ± 13.3 (18-64)
Device (no. patients), n (%)
PillCam® SB1	13 (36.1)
PillCam® SB2	16 (44.4)
PillCam® SB3	1 (2.8)
Mirocam®	5 (13.9)
Endocapsule®	1 (2.8)
Gastric transit time (min)	38.6 ± 44.7 (2–257)
Small bowel transit time (min)	290.4 ± 101.5 (52-480)
Incomplete SBCE	1 (2.8)
Capsule retention	0
Follow-up (mo) before SBCE	30.2 ± 29.9 (1-108)
Follow-up (mo) after SBCE	51.9 ± 40.5 (12-156)

IBDU: Inflammatory bowel disease type unclassified; SB: Small bowel; SBCE: Small bowel capsule endoscopy.